These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 23182839)
1. Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions. Khan SS; Secades-Villa R; Okuda M; Wang S; Pérez-Fuentes G; Kerridge BT; Blanco C Drug Alcohol Depend; 2013 Jun; 130(1-3):101-8. PubMed ID: 23182839 [TBL] [Abstract][Full Text] [Related]
2. Psychiatric, psychosocial, and physical health correlates of co-occurring cannabis use disorders and nicotine dependence. Peters EN; Schwartz RP; Wang S; O'Grady KE; Blanco C Drug Alcohol Depend; 2014 Jan; 134():228-234. PubMed ID: 24183498 [TBL] [Abstract][Full Text] [Related]
3. Gender differences in lifetime alcohol dependence: results from the national epidemiologic survey on alcohol and related conditions. Khan S; Okuda M; Hasin DS; Secades-Villa R; Keyes K; Lin KH; Grant B; Blanco C Alcohol Clin Exp Res; 2013 Oct; 37(10):1696-705. PubMed ID: 23763329 [TBL] [Abstract][Full Text] [Related]
4. DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles. Kerridge BT; Pickering R; Chou P; Saha TD; Hasin DS Addict Behav; 2018 Jan; 76():52-60. PubMed ID: 28755613 [TBL] [Abstract][Full Text] [Related]
5. The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC). Buckner JD; Heimberg RG; Schneier FR; Liu SM; Wang S; Blanco C Drug Alcohol Depend; 2012 Jul; 124(1-2):128-34. PubMed ID: 22266089 [TBL] [Abstract][Full Text] [Related]
6. Probability and correlates of dependence among regular users of alcohol, nicotine, cannabis, and cocaine: concurrent and prospective analyses of the National Epidemiologic Survey on Alcohol and Related Conditions. Cougle JR; Hakes JK; Macatee RJ; Zvolensky MJ; Chavarria J J Clin Psychiatry; 2016 Apr; 77(4):e444-50. PubMed ID: 27137428 [TBL] [Abstract][Full Text] [Related]
7. Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates. Lev-Ran S; Le Foll B; McKenzie K; George TP; Rehm J Psychiatry Res; 2013 Oct; 209(3):459-65. PubMed ID: 23312479 [TBL] [Abstract][Full Text] [Related]
8. [Comorbidity in 207 cannabis users in a specific outpatient setting]. Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065 [TBL] [Abstract][Full Text] [Related]
9. Cannabis use disorders among adults in the United States during a time of increasing use of cannabis. Compton WM; Han B; Jones CM; Blanco C Drug Alcohol Depend; 2019 Nov; 204():107468. PubMed ID: 31586809 [TBL] [Abstract][Full Text] [Related]
10. Cannabis use, cannabis use disorder and mental health disorders among pregnant and postpartum women in the US: A nationally representative study. Brown QL; Shmulewitz D; Sarvet AL; Young-Wolff KC; Howard T; Hasin DS Drug Alcohol Depend; 2023 Jul; 248():109940. PubMed ID: 37267745 [TBL] [Abstract][Full Text] [Related]
11. Gender differences in firesetting: results from the national epidemiologic survey on alcohol and related conditions (NESARC). Hoertel N; Le Strat Y; Schuster JP; Limosin F Psychiatry Res; 2011 Dec; 190(2-3):352-8. PubMed ID: 21684614 [TBL] [Abstract][Full Text] [Related]
12. Severity of DSM-5 cannabis use disorders in a nationally representative sample of sexual minorities. Boyd CJ; Veliz PT; McCabe SE Subst Abus; 2020; 41(2):191-195. PubMed ID: 31638867 [No Abstract] [Full Text] [Related]
13. Probability and correlates of transition from cannabis use to DSM-5 cannabis use disorder: Results from a large-scale nationally representative study. Feingold D; Livne O; Rehm J; Lev-Ran S Drug Alcohol Rev; 2020 Feb; 39(2):142-151. PubMed ID: 31916333 [TBL] [Abstract][Full Text] [Related]
14. Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Lev-Ran S; Imtiaz S; Taylor BJ; Shield KD; Rehm J; Le Foll B Drug Alcohol Depend; 2012 Jun; 123(1-3):190-200. PubMed ID: 22143039 [TBL] [Abstract][Full Text] [Related]
15. DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults. Livne O; Shmulewitz D; Lev-Ran S; Hasin DS Drug Alcohol Depend; 2019 Feb; 195():170-177. PubMed ID: 30361043 [TBL] [Abstract][Full Text] [Related]
16. Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016. Santaella-Tenorio J; Levy NS; Segura LE; Mauro PM; Martins SS Drug Alcohol Depend; 2019 Dec; 205():107621. PubMed ID: 31698323 [TBL] [Abstract][Full Text] [Related]
17. Probability and predictors of cannabis use disorders relapse: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Flórez-Salamanca L; Secades-Villa R; Budney AJ; García-Rodríguez O; Wang S; Blanco C Drug Alcohol Depend; 2013 Sep; 132(1-2):127-33. PubMed ID: 23415849 [TBL] [Abstract][Full Text] [Related]
18. Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Compton WM; Conway KP; Stinson FS; Colliver JD; Grant BF J Clin Psychiatry; 2005 Jun; 66(6):677-85. PubMed ID: 15960559 [TBL] [Abstract][Full Text] [Related]
19. DSM-IV criteria-based clinical subtypes of cannabis use disorders: results from the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). Blanco C; Ogburn E; Pérez de Los Cobos J; Lujan J; Nunes EV; Grant B; Liu SM; Hasin DS Drug Alcohol Depend; 2008 Jul; 96(1-2):136-44. PubMed ID: 18420357 [TBL] [Abstract][Full Text] [Related]
20. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample. Hayley AC; Stough C; Downey LA Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]